Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention

被引:7
|
作者
Konstan, Michael W. [1 ]
Wagener, Jeffrey S. [2 ]
VanDevanter, Donald R. [1 ]
Pasta, David J. [3 ]
Millar, Stefanie J. [3 ]
Morgan, Wayne J. [4 ]
机构
[1] Case Western Reserve Univ, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
[3] ICON Clin Res, San Francisco, CA USA
[4] Univ Arizona, Tucson, AZ USA
关键词
cystic fibrosis; dornase alfa; epidemiology; pulmonary function; PULMONARY-FUNCTION; REFERENCE VALUES; CLINICAL-USE; SPIROMETRY; CHILDREN; DECLINE; AGE; US;
D O I
10.1002/ppul.23751
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: The Global Lung Function Initiative (GLI, 2012) developed reference equations for forced expiratory volume in 1 s (FEV1). Previous equations were developed by groups led by Knudson (1983), Wang (1993), Hankinson (1999), and Stanojevic (2008). 1,2,4,6 We assessed how different prediction equations affect the conclusions from a therapeutic intervention study that evaluated the rate of percent predicted FEV1 (ppFEV(1)) decline. Methodology: Using data from the Epidemiologic Study of cystic fibrosis (CF), we re-analyzed our previous study evaluating the relationship of dornase alfa (DA) use with ppFEV(1) using the Knudson, Wang & Hankinson, Stanojevic, and GLI equations. The change in intercept and change in slope of ppFEV(1) from a 2-year pre-index period and 2-year post-index period were compared between the treated (N = 2483) and comparator groups (N = 6992, from 4110 unique patients). Results: Change in intercept for the comparator group was similar across equations except that Wang& Hankinson values were more negative. The difference in change in intercept between the DA and comparator groups ranged from 3.38 to 4.02% predicted. The change in slope for the comparator group ranged from -0.58 to +0.30 ppFEV(1)/year, but the difference in change in slope between the DA and comparator groups was in a narrower range from +0.53 to +0.89 ppFEV(1)/year. Conclusions: Although individual patient results are impacted by the choice of reference equations, the study conclusions from this evaluation of a therapeutic intervention were minimally affected. GLI equations are recommended for future studies, but prior results based on other equations should be accepted as reliable.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 50 条
  • [1] COMPARISON OF FEV1 PREDICTION EQUATIONS FOR EVALUATING A CF THERAPEUTIC INTERVENTION
    Konstan, M.
    Wagener, J.
    VanDevanter, D.
    Pasta, D. J.
    Millar, S. J.
    Morgan, W. J.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 355 - 356
  • [2] FEV1 decline in cystic fibrosis
    Miller, Martin
    THORAX, 2013, 68 (03) : 294 - 294
  • [3] Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
    Boelle, Pierre-Yves
    Viviani, Laura
    Busson, Pierre-Francois
    Olesen, Hanne V.
    Ravilly, Sophie
    Stern, Martin
    Assael, Baroukh M.
    Barreto, Celeste
    Drevinek, Pavel
    Thomas, Muriel
    Krivec, Uros
    Mei-Zahav, Meir
    Vibert, Jean-Francois
    Clement, Annick
    Mehta, Anil
    Corvol, Harriet
    ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
  • [4] REFERENCE PERCENTILES FOR FEV1 AND BMI IN EUROPEAN CHILDREN AND ADULTS WITH CYSTIC FIBROSIS
    Corvol, H.
    Boelle, P.
    Viviani, L.
    Busson, P.
    Olesen, H., V
    Ravilly, S.
    Stern, M.
    Assael, B. M.
    Barreto, C.
    Drevinek, P.
    Thomas, M.
    Krivec, U.
    Mei-Zahav, M.
    Vibert, J.
    Clement, A.
    Mehta, A.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 359 - 359
  • [5] Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
    Pierre-Yves Boëlle
    Laura Viviani
    Pierre-Francois Busson
    Hanne V Olesen
    Sophie Ravilly
    Martin Stern
    Baroukh M Assael
    Celeste Barreto
    Pavel Drevinek
    Muriel Thomas
    Uros Krivec
    Meir Mei-Zahav
    Jean-François Vibert
    Annick Clement
    Anil Mehta
    Harriet Corvol
    Orphanet Journal of Rare Diseases, 7
  • [6] Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis
    Bouzek, Drake C.
    Ren, Clement L.
    Thompson, Misty
    Slaven, James E.
    Sanders, Don B.
    PEDIATRIC PULMONOLOGY, 2022, 57 (07) : 1709 - 1716
  • [7] The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis,*
    Rosenfeld, Margaret
    Cromwell, Elizabeth A.
    Schechter, Michael S.
    Ren, Clement
    Flume, Patrick A.
    Szczesniak, Rhonda D.
    Morgan, Wayne J.
    Jain, Raksha
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (03) : 443 - 449
  • [8] THE GLI SPIROMETRY REFERENCE EQUATIONS INFLUENCE THE APPARENT RATE OF DECLINE IN FEV1 AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
    Davies, G.
    Aurora, P.
    McDonald, A.
    Prasad, A.
    Bilton, D.
    Stocks, J.
    Stanojevic, S.
    THORAX, 2014, 69 : A37 - A37
  • [9] Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries
    Kim, Sang-Ook
    Corey, Mary
    Stephenson, Anne L.
    Strug, Lisa J.
    THORAX, 2018, 73 (05) : 446 - 450
  • [10] LUNG VASCULAR CHANGES WITH FEV1% IN PATIENTS WITH CYSTIC FIBROSIS
    Mylavarapu, G.
    Estepar, R.
    Tadesse, D. G.
    Hossain, M. M.
    Fleck, R. J.
    Woods, J. C.
    Naren, A.
    Amin, R.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S206 - S206